Sun Pharma News
Sun Pharma investors await clarity on US tariff after weak Q2
India’s largest drugmaker posted modest profit growth in Q2FY26 as US sales fell and input costs rose. Investors now look for clarity on potential US import tariffs and their impact on margins.
2 min read7 Nov 2025Sun Pharma beats Street—Q2 net profit up 2.6%, US sales down 4%
Sun Pharmaceutical retained its top position by sales, and its domestic market share increased marginally from 8% to 8.3%, the company said. It launched nine new products during the quarter and 15 products year to date.
3 min read5 Nov 2025Wockhardt, Sun Pharma, Lupin, Alembic Pharma, other pharma stocks rebound up to 10% after clarification on Trump Tariffs
Shares of Wockhardt rallied over 10%, leading the recovery in the sector. Bajaj Healthcare, Supriya Lifescience, Alembic Pharmaceuticals, Aster DM Healthcare, Sun Pharmaceutical Industries, Lupin, Cipla, Aarti Drugs, Zydus Lifesciences, Biocon, and others gained between 1–3%.
2 min read29 Sep 2025Trump's pharma tariffs: Sun Pharma, Cipla to Dr Reddy's — why experts see a sharp rebound on Monday? EXPLAINED
Trump's pharma tariffs: Analysts believe Indian pharma companies, primarily focused on generics, will largely avoid impact due to the tariffs being aimed at branded drugs
2 min read27 Sep 2025Threat of US tariffs hangs over Sun Pharma’s specialty business
While pharma is currently exempt from US tariffs, the sector is under investigation and could face levies depending on the outcome. These would hit Sun Pharma’s specialty business – which grew almost three times faster than the overall business over FY21-25 – the hardest.
2 min read23 Sep 2025Sun Pharma has shuffled its top deck. The bet is on.
Sun Pharma’s leadership changes—spanning its globally critical functions, including the India business, the US, and its long-term speciality focus—mark a strategic long-term transition.
5 min read20 Sep 2025Now Sun Pharma, Lupin work on anti-obesity pill to cut costs, address jab aversion
Sun Pharma and Lupin pursue regulatory approval for oral weight-loss drugs, potentially reshaping treatment access.
3 min read8 Sep 2025Ajanta Pharma, Lupin to Sun Pharma: Why are pharma stocks falling despite Trump’s tariff exemption?
Ajanta Pharma, Gland Pharma, Lupin, Aurobindo Pharma, Sun Pharmaceutical Industries, Zydus Lifesciences, Divi's Laboratories and Torrent Pharmaceuticals were among the top losers in the Nifty Pharma index, which shed over 1% during the session.
2 min read28 Aug 2025Sun Pharma shares fall 5.7% post Q1 results: What should investors do now?
Sun Pharmaceutical's shares fell 5.7% to ₹1,608.30 after a 20% drop in net profit to ₹2,278 crore for Q1 FY26. Despite this, revenue grew 9% to ₹13,851 crore, supported by strong performances in key markets.
2 min read1 Aug 2025Sun Pharma net profit falls on US antitrust settlement, drug impairment costs
Healthy double-digit growth in its India business and innovative medicines pipeline boosted its revenue and Ebitda margins during the quarter. The drugmaker has been banking on both segments to drive growth in FY26.
2 min read31 Jul 2025Popular Topics
Budget
The Union Budget contains details about the estimated receipts and the expenditure of the government for a particular fiscal year. The Budget is allotted for the upcoming fiscal year, which runs from 1st April to 31st March of the next year. Here is a quick guide on how the Union Budget is prepared
Wait for it…
Oops! Looks like you have exceeded the limit to bookmark the image. Remove some to bookmark this image.